"Since our founding in 2013, Co-Diagnostics has been at the forefront of PCR technology innovation, beginning with the introduction of the revolutionary Co-Primers® technology, and later with the ...

BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Conformité ...

On October 29, 2025, Bio-Rad Laboratories reported third-quarter earnings with sales of US$653 million and a net loss of US$341.9 million, while also completing a major share repurchase and announcing ...

By leveraging advanced Polymerase Chain Reaction (PCR) technology with streamlined testing for a broad range of gastrointestinal (GI) bacterial pathogens from a single stool swab sample, the panels ...

Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of ...

Biodesix expands its Bio-Rad partnership to validate ddPCR cancer assays, starting with ESR1 mutation testing in breast ...

Giovanna Prout joins Countable Labs as CEO to accelerate commercialization of Countable Labs’ products Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a ...

In the summer of 1812, French emperor Napoleon Bonaparte led about half a million soldiers to invade the Russian Empire. But ...

Napoleon I led an army of around 550,000 soldiers to invade Russia in June 1812, but they didn't make it home. | Microbiology ...

As technological advancements contribute to more facilities mechanically or chemically recycling film, lacking end markets ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), and Gencurix, Inc. (KOSDAQ: 229000), announced the signing of a strategic agreement establishing Bio-Rad as the exclusive distributor of Gencurix’ ...